Evotec Achieves Further Milestones in TargetAD Collaboration With Janssen
15 janv. 2015 01h35 HE
|
Evotec AG
HAMBURG, Germany, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced the achievement of several small, but very important milestones in its...
Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration
07 janv. 2015 01h37 HE
|
Evotec AG
HAMBURG, Germany, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Padlock Therapeutics, Inc. ("Padlock") announced today that they have successfully...
Evotec and Ohio State to Collaborate on Novel Cancer Therapy
22 déc. 2014 01h42 HE
|
Evotec AG
Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure
Efforts will explore the use of a novel approach, discovered at Ohio State, for targeting mutant...
Achievement of Multiple Milestones in Evotec's Drug Discovery Alliances
18 déc. 2014 11h36 HE
|
Evotec AG
HAMBURG, Germany, Dec. 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) disclosed today that it achieved multiple milestones in ongoing alliances with its strategic...
Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration
02 déc. 2014 12h42 HE
|
Evotec AG
Parties have entered into exclusive negotiations and expect to sign the transaction in H1 2015
Goal to improve innovation effectiveness in drug discovery and pre-clinical...
Evotec Reports Results of the First Nine Months of 2014
12 nov. 2014 01h57 HE
|
Evotec AG
STRONG OPERATIONAL PERFORMANCE, POSITIVE EBITDA
UNIQUE STRATEGIC POSITION DESPITE RECENT DIAPEP277® SETBACK
IMPORTANT MILESTONES EXPECTED FOR Q4
VERY STRONG CASH...
Evotec to Report Results for the First Nine Months of 2014 on 12 November 2014
05 nov. 2014 06h59 HE
|
Evotec AG
HAMBURG, Germany, Nov. 5, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first nine months of 2014 on Wednesday, 12 November...
Evotec Receives Milestone as Part of Its Multi-Target Alliance With Bayer HealthCare
30 sept. 2014 01h38 HE
|
Evotec AG
HAMBURG, Germany, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that its multi-target collaboration with Bayer HealthCare ("Bayer") has...
Evotec and Its Partners Awarded Public Grants to Develop New Drug Candidates to Treat Multiple Sclerosis
24 sept. 2014 01h34 HE
|
Evotec AG
HAMBURG, Germany, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that it has entered into three novel research projects for the treatment of...
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
18 sept. 2014 01h35 HE
|
Evotec AG
HAMBURG, Germany, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today after careful evaluation that it will take legal steps against Israel-based...